New Stem Cell Approach Paves Way for Type 1 Diabetes Cure
A GROUNDBREAKING preclinical study has demonstrated that a chemotherapy-free, non-myeloablative conditioning regimen can induce durable mixed haematopoietic chimerism, restore immune tolerance, and completely reverse autoimmune type 1 diabetes in mouse models. The findings could pave…